Bristol-Myers Squibb has issued a `Dear Health Care Provider' letter advising of a change in the pregnancy category for Sustiva [efavirenz]

By  

Reactions Weekly, Vol. 1, Iss. 1056, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Jones Pharma Incorporated has issued a `Dear Healthcare Professional' letter advising of changes to the US labelling of Levoxyl [levothyroxine sodium].

By  

Reactions Weekly, Vol. 1, Iss. 1023, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Cephalon has issued a "Dear Healthcare Professional" letter announcing that modafinil [Provigil] is now only indicated

By  

Reactions Weekly, Vol. 1, Iss. 1343, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Sanofi-aventis has issued a `Dear Healthcare Professional' letter outlining changes to the Ketek [telithromycin] label

By  

Inpharma, Vol. 1, Iss. 1581, 2007-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Eli Lilly has issued a `Dear Healthcare Professional' letter to advise of a new warning on the US Xigris [drotrecogin alfa] label

By  

Reactions Weekly, Vol. 1, Iss. 1044-1045, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite